Craig B. Thompson

Filings by Craig B. Thompson span 3 companies, the busiest being Charles River Laboratories International, Inc., Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc. In total, 24 filings cover trades dated from 30 May 2008 to 2 January 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 6 January 2026 with a share grant in Regeneron Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.